US2020289548A1PendingUtilityA1
Fucoidan hair growth agent
Assignee: COSMED PHARMACEUTICAL CO LTDPriority: Mar 16, 2016Filed: Mar 16, 2017Published: Sep 17, 2020
Est. expiryMar 16, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61K 8/73A61M 37/0015A61Q 7/00A61K 36/23A61M 2037/0061A61K 2800/87A61K 8/02A61P 17/14A61M 2037/0023A61K 9/06A61K 31/737A61K 2800/88A61K 2800/91A61K 36/9068
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
To develop a novel administration method of a fucoidan-containing hair-growing agent and to provide a means for exerting excellent effects of a fucoidan. A hair-growing agent of the present invention is characterized in that it is composed of a combination of a fucoidan-containing microneedle and a fucoidan-containing liniment. A base of the fucoidan-containing microneedle is preferably a biosoluble polymer. A hair-growing method of the present invention is characterized in that the fucoidan-containing microneedle and the fucoidan-containing liniment are concomitantly used.
Claims
exact text as granted — not AI-modified1 . A hair-growing agent composed of a combination of a fucoidan-containing microneedle and a fucoidan-containing liniment.
2 . The hair-growing agent according to claim 1 , wherein a base of the fucoidan-containing microneedle is a biosoluble polymer.
3 . The hair-growing agent according to claim 1 , wherein the fucoidan in the fucoidan-containing microneedle and the fucoidan-containing liniment is derived from a brown alga.
4 . The hair-growing agent according to any one of claims 1 to 3 , further containing a carrot extract and a ginger tincture as a drug.
5 . A hair-growing method (excluding medical practice), wherein the fucoidan-containing microneedle and the fucoidan-containing liniment are concomitantly used.
6 . A hair-growing agent composed of a fucoidan-containing microneedle alone.Join the waitlist — get patent alerts
Track US2020289548A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.